Bryan Kobel
Chief Executive Officer bei TC BIOPHARM (HOLDINGS) PLC
Vermögen: 773 $ am 30.11.2023
Profil
Bryan Kobel is currently the Chief Executive Officer & Director at TC Biopharm (Holdings) Plc, as well as the CEO-Biopharm North America and Chief Executive Officer at TC BioPharm (North America), Inc. He previously worked as the Managing Director at Laidlaw & Co. (UK) Ltd.
from 2012 to 2017, Managing Director at The Alberleen Group LLC from 2018 to 2020, and Head-Capital Markets at R.F.
Lafferty & Co., Inc. from 2017 to 2018.
He also served as the Head-Healthcare Investment Banking at HUTN, Inc. Mr. Kobel received his undergraduate degree from Franklin & Marshall College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 06.02.2024 | 2 101 ( 0,22% ) | 773 $ | 30.11.2023 |
Aktive Positionen von Bryan Kobel
| Unternehmen | Position | Beginn |
|---|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Chief Executive Officer | 01.06.2021 |
TCB Newco Ltd.
 TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Corporate Officer/Principal | - |
| TC BioPharm (North America), Inc. | Chief Executive Officer | 01.06.2021 |
Ehemalige bekannte Positionen von Bryan Kobel
| Unternehmen | Position | Ende |
|---|---|---|
The Alberleen Group LLC
 The Alberleen Group LLC Investment Banks/BrokersFinance The Alberleen Group LLC provides investment banking services. The firm offers mergers, acquisitions advice, capital raising services, investment opportunities and merchant banking services. It serves to the energy, financials, healthcare, real estate industries. The company was founded by Jolyne Caruso in July 2010 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.10.2020 |
R.F. Lafferty & Co., Inc.
 R.F. Lafferty & Co., Inc. Investment Banks/BrokersFinance Founded in 1946, R.F. Lafferty & Co., Inc. is a brokerage firm and registered investment advisor located in New York City. The firm's research focuses on small- and mid-cap companies. | Corporate Officer/Principal | 01.06.2018 |
Laidlaw & Co. (UK) Ltd.
 Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Part of Laidlaw Holdings Ltd., Laidlaw & Co. (UK) Ltd. is a British company that provides investment advice. The private company is based in London, UK. The company was founded in 1842. Matthew D. Eitner has been the CEO of the company since 2010. | Corporate Officer/Principal | 01.04.2017 |
| HUTN, INC. | Corporate Officer/Principal | - |
Ausbildung von Bryan Kobel
| Franklin & Marshall College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| HUTN, INC. | Finance |
| TC BIOPHARM (HOLDINGS) PLC | Health Technology |
| Private Unternehmen | 5 |
|---|---|
R.F. Lafferty & Co., Inc.
R.F. Lafferty & Co., Inc. Investment Banks/BrokersFinance Founded in 1946, R.F. Lafferty & Co., Inc. is a brokerage firm and registered investment advisor located in New York City. The firm's research focuses on small- and mid-cap companies. | Finance |
Laidlaw & Co. (UK) Ltd.
Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Part of Laidlaw Holdings Ltd., Laidlaw & Co. (UK) Ltd. is a British company that provides investment advice. The private company is based in London, UK. The company was founded in 1842. Matthew D. Eitner has been the CEO of the company since 2010. | Finance |
The Alberleen Group LLC
The Alberleen Group LLC Investment Banks/BrokersFinance The Alberleen Group LLC provides investment banking services. The firm offers mergers, acquisitions advice, capital raising services, investment opportunities and merchant banking services. It serves to the energy, financials, healthcare, real estate industries. The company was founded by Jolyne Caruso in July 2010 and is headquartered in New York, NY. | Finance |
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Health Technology |
| TC BioPharm (North America), Inc. |
